Dec 6, 2025 08:30AM
Nov 24, 2025 07:30AM
Jul 1, 2025 07:30AM
Jun 18, 2025 09:28AM
May 30, 2025 07:30AM
May 30, 2025 07:30AM
Apr 8, 2025 08:09AM Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
Apr 8, 2025 08:00AM
Mar 11, 2025 08:00AM
Feb 11, 2025 04:05PM
Jan 14, 2025 07:30AM
Jan 14, 2025 07:30AM
Jan 7, 2025 07:30AM
Dec 18, 2024 06:30AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $9 at BTIG
Dec 7, 2024 06:30PM
Dec 3, 2024 07:30AM
Nov 7, 2024 07:31AM
Nov 7, 2024 07:30AM
Oct 15, 2024 05:53AM
Aug 29, 2024 07:31AM
Aug 29, 2024 07:30AM Adaptive Announces IVDR Certification for clonoSEQ® in European Union
May 31, 2024 07:30AM
May 31, 2024 07:30AM
May 7, 2024 04:05PM
Dec 9, 2023 08:30AM
Dec 5, 2023 07:30AM
Nov 7, 2023 07:30AM
Sep 13, 2023 07:31AM Adaptive Biotechnologies (ADPT) Announces Launch of Epic Integration for clonoSEQ
Sep 13, 2023 07:30AM
Aug 2, 2023 04:05PM
Jun 2, 2023 07:34AM
May 9, 2023 07:31AM
May 9, 2023 07:30AM
Apr 12, 2023 07:31AM
Apr 12, 2023 07:30AM Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
Apr 12, 2023 07:30AM
Dec 10, 2022 10:00AM
Dec 10, 2022 10:00AM
Dec 5, 2022 07:30AM
Dec 5, 2022 07:30AM
Dec 1, 2022 07:30AM
Oct 11, 2022 08:05AM Adaptive Biotechnologies (ADPT) Partners with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers
Oct 11, 2022 08:05AM
Oct 11, 2022 08:05AM
Jul 28, 2022 07:30AM
Jul 28, 2022 07:30AM
Jun 15, 2022 07:30AM
Jun 15, 2022 07:30AM
Jun 15, 2022 07:30AM Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
Jun 2, 2022 04:10PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All